image

The best stocks to buy since 1993

Latest issue now available

Fusionex - FY16 to be an investment year

February 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FXI
  • Price:
  • 155p
Fusionex has reported FY15 results with sales up 35% to RM77m. Adjusted pretax profit was up from RM23.7m to RM31m, although this was after Fusionex capitalised RM16.5m development costs (which it then writes off over five years). The year saw it build its geographic coverage and increase its reseller network (SI Mesiniaga Berhad and Dell joining Avnet, EMC, Microsoft/Revolution Analytics) and consequently it exceeded the number of installations  of its flagship Big Data product, GIANT, which grew to 36, up from just 12, so two new signups each month on average.  Speaking to Ivan Teh, he notes that GIANT contracts are typically for three to five years so the RM68m recorded in product sales should mostly repeat this year. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe